FOS and rhabdoid tumor: Collectively, these findings shed light on a recurring molecular mechanism contributing to the dysregulation of enhancer- and super-enhancer-mediated gene expression in rhabdoid tumor cells and suggests that AP-1 transcription factors may be underlying factors involved in this process.